Biobanking at RCSI
Biobanks are collections of biological samples (such as blood, DNA or tissue) and associated data (such as clinical information) established to support scientific knowledge. Biobanks are an invaluable resource in the global effort for more precise and personalised medicines. RCSI investigators have established and manage a number of important biobanks, often working closely with our partner hospitals and studying the data with collaborators around the world. For example, data from RCSI biobanks have helped inform safer prescribing of treatments for epilepsy, avoiding dangerous adverse reactions. They have also facilitated more accurate diagnosis for subtypes of alpha-1 deficiency syndrome, which in turn can guide treatments that target the underlying cause of disease. As more data becomes available through biobanks, researchers can use these resources to advance patient treatment and improve outcomes.
To help support our investigators, the University has developed the RCSI Biobanking Service, which in combination with the Office of Research and Innovation offers a number of supports:
- A tissue biobanking service. This service facilitates the collection of well-annotated fresh frozen and formalin-fixed tumour and normal breast, colon, prostate, skin, renal and other tissue samples. This service facilitates research with collaborators in other institutions and a number of programme and project grants from SFI, HRB, Wellcome Trust, HEA and the Irish Cancer Society.
- A DNA processing and storage service for blood and saliva samples. The DNA extraction and biobanking service facilitates the SFI FutureNeuro Research Centre and a number of other grant funded activities from EI, HRB and HEA.
For further information, please contact Prof. Gianpiero Cavalleri.